Barclays Merchant Bank buys stake in Manappuram, Shilpa Medicare
Barclays Merchant Bank (Singapore) bought 31.74 million shares of Manappuram at Rs 97.30 per share.
 "Barclays Merchant Bank buys stake in Manappuram, Shilpa Medicare")
premium
Barclays Merchant Bank (Singapore) have bought stake in gold finance company Manappuram Finance and in pharmaceutical company Shilpa Medicare for total consideration of Rs 414 crore through open market transaction.
Barclays Merchant Bank (Singapore) has bought 31.74 million equity shares representing 3.77% stake in Manappuram Finance from Barring India Private Equity Fund III Listed Investment Ltd in block deal through National Stock Exchange (NSE) on Tuesday. The shares were acquired for an average price of Rs 97.30 apiece, bringing the transaction value to Rs 309 crore.
As of December 31, 2016, Barring India Private Equity Fund III held 9.43% stake in Manappuram Finance, the shareholding pattern data shows.
The company on Monday, February 27, said the board of directors of the company will meet on March 17, 2017 to consider the business plan of the company for the financial year 2017-18.
At 12:05 pm; the stock was up 6% at Rs 103 on the NSE as compared to 0.50% rise in the Nifty 50 index.
Barclays Merchant Bank (Singapore) also purchased 1.61 million shares or 2% stake in Shilpa Medicare from CLSA Global Markets PTE Ltd through block deal on the NSE. The shares were acquired for an average price of Rs 651 per share, bringing the transaction value to Rs 105 crore.
CLSA Global Markets PTE Ltd was held 3.21% stake in pharmaceutical company at the end of December quarter.
The stock of Shilpa Medicare was trading 1.5% higher at Rs 650 on the NSE.
In other Indian companies in which Barclays Merchant Bank (Singapore) held more than 1% stake include Sintex Industries, Dabur India, Indoco Remedies and Vardhman Textiles.
Meanwhile, Barclays Global Fund Advisors A/c Ishares India Mauritius Company has acquired six million shares of Grasim Industries at price of Rs 990 per share, bringing the transaction value to Rs 595 crore. Integrated Core Strategies (Asia) PTE Ltd sold 2.93 million shares at Rs 989.66 per share, the NSE data shows. The stock of Grasim Industries was trading 0.5% higher at Rs 995, after falling 2.75% on Tuesday.
Barclays Merchant Bank (Singapore) has bought 31.74 million equity shares representing 3.77% stake in Manappuram Finance from Barring India Private Equity Fund III Listed Investment Ltd in block deal through National Stock Exchange (NSE) on Tuesday. The shares were acquired for an average price of Rs 97.30 apiece, bringing the transaction value to Rs 309 crore.
As of December 31, 2016, Barring India Private Equity Fund III held 9.43% stake in Manappuram Finance, the shareholding pattern data shows.
The company on Monday, February 27, said the board of directors of the company will meet on March 17, 2017 to consider the business plan of the company for the financial year 2017-18.
At 12:05 pm; the stock was up 6% at Rs 103 on the NSE as compared to 0.50% rise in the Nifty 50 index.
Barclays Merchant Bank (Singapore) also purchased 1.61 million shares or 2% stake in Shilpa Medicare from CLSA Global Markets PTE Ltd through block deal on the NSE. The shares were acquired for an average price of Rs 651 per share, bringing the transaction value to Rs 105 crore.
CLSA Global Markets PTE Ltd was held 3.21% stake in pharmaceutical company at the end of December quarter.
The stock of Shilpa Medicare was trading 1.5% higher at Rs 650 on the NSE.
In other Indian companies in which Barclays Merchant Bank (Singapore) held more than 1% stake include Sintex Industries, Dabur India, Indoco Remedies and Vardhman Textiles.
Meanwhile, Barclays Global Fund Advisors A/c Ishares India Mauritius Company has acquired six million shares of Grasim Industries at price of Rs 990 per share, bringing the transaction value to Rs 595 crore. Integrated Core Strategies (Asia) PTE Ltd sold 2.93 million shares at Rs 989.66 per share, the NSE data shows. The stock of Grasim Industries was trading 0.5% higher at Rs 995, after falling 2.75% on Tuesday.
| | Client Name | Type | Shares (Mn) | |
| Grasim Ind | BARCLAYS GLOBAL FUND ADVISORS A/C ISHARES INDIA MAURITIUS | BUY | 6.01 | 990.23 |
| Grasim Ind | INTEGRATED CORE STRATEGIES (ASIA) PTE.LTD. | SELL | 2.93 | 989.66 |
| Manappuram Finance | BARCLAYS MERCHANT BANK (SINGAPORE) LIMITED | BUY | 31.74 | 97.30 |
| Manappuram Finance | BARING INDIA PRIVATE EQUITY FUND III LISTED INVESTMENTS LTD | SELL | 31.74 | 97.30 |
| Shilpa Medicare | BARCLAYS MERCHANT BANK (SINGAPORE) LIMITED | BUY | 1.61 | 651.00 |
| Shilpa Medicare | CLSA GLOBAL MARKETS PTE LTD | SELL | 1.61 | 651.00 |
| Source : NSE | ||||
| Transaction date: 28/02/2017 | ||||
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%